{
    "code": 0,
    "data": [
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Earnings call conducted on February 9 2026",
            "news_id": "9a6e67ce-ec66-4a1a-b0c3-93295680dd85",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=990e5098-04e9-43e1-87c7-47605c516fdc.pdf",
            "news_date": "2026-02-09 19:44:19",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the Financial Results of the Company for the quarter and nine months ended December 31 2025",
            "news_id": "369a5dc2-70ec-4130-ae23-9ee8cb5a2bb5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f789c6ae-40ed-49ab-8264-dc74f0976e23.pdf",
            "news_date": "2026-02-09 16:29:30",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025",
            "news_id": "3b117d33-a190-4081-8ac6-18495ca221c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5ea88c1-f9c1-40b9-ab7b-e5dc38523e8d.pdf",
            "news_date": "2026-02-09 16:14:22",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call conducted on November 7 2025",
            "news_id": "15ab8d43-a8b1-4f5c-8270-6b1f3afa3958",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9431d47d-166e-4f67-90b3-7e7a20bdaf2e.pdf",
            "news_date": "2025-11-12 13:57:01",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Earnings call conducted on November 7 2025",
            "news_id": "29bee6a2-4a4d-459c-b400-b502dddf0e40",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3feb2c9d-9e98-4eca-ac45-7f179bc6069a.pdf",
            "news_date": "2025-11-07 20:33:56",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the Financial Results of the Company for the quarter and half year ended September 30 2025",
            "news_id": "2820888b-094e-4241-b0d3-b2da6cf7475c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f4a2a49-c8a4-4d3b-92d1-0149798a4093.pdf",
            "news_date": "2025-11-07 16:34:46",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025",
            "news_id": "f00fe4e6-ae55-4160-bf68-c15a885553cb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a60f15e2-578b-4a0c-bba3-be249a9fd4e0.pdf",
            "news_date": "2025-11-07 16:22:18",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call conducted on July 31 2025",
            "news_id": "43fe6a46-b90d-4630-8bde-51705cbc8c84",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10f22588-7577-4d88-9621-acbbc292eb59.pdf",
            "news_date": "2025-08-04 17:33:13",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Earnings call conducted on July 31 2025",
            "news_id": "ff355a18-1cd1-405a-91e5-d4667e18353e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4d84315-7d3c-4703-b959-af8eb8cfde44.pdf",
            "news_date": "2025-07-31 20:51:41",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the Financial Results of the Company for the quarter ended June 30 2025",
            "news_id": "602a1271-9252-438d-a11c-9ed7a473c387",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f91a6323-fca2-455a-809c-f3f2e7095ed2.pdf",
            "news_date": "2025-07-31 16:43:40",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Quarter Ended June 30 2025",
            "news_body": "Unaudited Financial results for the quarter ended June 30 2025",
            "news_id": "62dbb028-d036-44f4-afa1-9675fd984782",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1dcfffb6-a551-48fb-9a05-f75134edaceb.pdf",
            "news_date": "2025-07-31 16:21:02",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Earnings call conducted on May 15 2025",
            "news_id": "fd39fc48-993d-4b2d-b69a-fe3a23ac9c0d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96516106-9f51-4c7e-943d-a9e39f13dd7c.pdf",
            "news_date": "2025-05-15 20:04:34",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the Financial Results of the Company for the quarter and year ended March 31 2025",
            "news_id": "790bdbb2-7786-453f-92bd-b876a9851b12",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12bfa8ba-de7c-435e-9104-c0ef26b66c6a.pdf",
            "news_date": "2025-05-15 16:29:03",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2024-25",
            "news_body": "Audited Financial Results and recommendation of final dividend for financial year 2024-25",
            "news_id": "8677fb87-2439-4303-b949-69989a30d450",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c60742c1-4eac-4e6d-8c25-7f65223a9e75.pdf",
            "news_date": "2025-05-15 16:13:41",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings call conducted on February 11 2025",
            "news_id": "a19ed75a-dedc-4ab7-8d48-e83765933010",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bb9ddcf-7706-48f6-bb1e-410ac37ceafe.pdf",
            "news_date": "2025-02-14 14:54:30",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the Financial Results of the Company for the quarter and nine months ended December 31 2024",
            "news_id": "dbf6c8c6-2264-447f-96b9-00e4c381ca95",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4b2a46e-abff-4f5d-95ba-6cf771b7f227.pdf",
            "news_date": "2025-02-10 16:43:27",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2024",
            "news_id": "0e3b9efa-033a-4a0d-ae74-1cf040ed76e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ac4a9d3-88ee-4993-b254-b80af101a895.pdf",
            "news_date": "2025-02-10 16:27:27",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings call conducted on November 6, 2024",
            "news_id": "1782f56b-d8e4-4236-8ee2-812b998142ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c46c264-3cd1-4c5f-b273-3db4d9b5ecd5.pdf",
            "news_date": "2024-11-12 11:42:50",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Earnings call conducted on November 6, 2024",
            "news_id": "0cc575cc-e3d0-46e7-9ae3-0f57c125a577",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe3cad1d-c952-40d1-93fb-32e74bf9da4c.pdf",
            "news_date": "2024-11-06 21:36:35",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors/Analysts Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 2024",
            "news_id": "1eeb5b7b-90ba-4ab4-a83b-37c3fe2caf31",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf538063-b638-4707-a799-347b298c3679.pdf",
            "news_date": "2024-11-06 13:23:04",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024",
            "news_id": "0a120d3c-626f-4cda-83e0-f2dbdd9e10b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a56b6d4-c047-4f29-a83d-10c22d17f36e.pdf",
            "news_date": "2024-11-06 13:11:23",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call conducted on August 1, 2024",
            "news_id": "767f542c-4c5f-495c-a824-186ee73330ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bc0207a-de4c-41f7-a720-c936fc796a2e.pdf",
            "news_date": "2024-08-06 12:41:59",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Earnings call conducted on August 1, 2024",
            "news_id": "7f8bc6a1-92e4-4543-9294-b22ea7a57c4d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46138374-83bf-4147-83f6-3185b3a6db41.pdf",
            "news_date": "2024-08-01 20:53:19",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors/Analysts Presentation on the Financial Results of the Company for the quarter ended June 30, 2024",
            "news_id": "443294ce-cd28-440c-bd05-8263f022d812",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e355da-4450-4458-938a-91eccff280d1.pdf",
            "news_date": "2024-08-01 16:20:07",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Quarter Ended June 30, 2024",
            "news_body": "Unaudited Financial results for quarter ended June 30, 2024",
            "news_id": "d706e9ef-dbe5-44b6-bdc1-d9676664a479",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9ef5edf-3e3c-4d9a-b7e8-10755cfbb691.pdf",
            "news_date": "2024-08-01 15:20:13",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings call conducted on May 14, 2024",
            "news_id": "f9519dcf-7469-4e13-b4ef-05f39e359685",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9de4118-f984-47bd-923d-5e1df7cdd67b.pdf",
            "news_date": "2024-05-17 14:19:49",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed the link of the audio recording of the Earnings call for the quarter and year ended March 31, 2024, conducted on May 14, 2024",
            "news_id": "08e5f4a7-a5a7-4034-aca8-d4318238bbbe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=608ee996-b308-4f00-8215-0cb676d1091e.pdf",
            "news_date": "2024-05-14 16:40:41",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Revised Investors Presentation on the Financial Results of the Company for the quarter and year ended March 31, 2024",
            "news_id": "e741b92a-d6b2-4795-9332-7378b76dc6d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44a45297-a7b7-4b81-af25-f5fa2069589a.pdf",
            "news_date": "2024-05-12 15:26:10",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation on the Financial Results of the Company for the quarter and year ended March 31, 2024",
            "news_id": "46281d3c-499d-48dc-9bf4-de8ee5979bdf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d776b27-f169-4664-9bac-7093c8c3fa56.pdf",
            "news_date": "2024-05-10 17:01:23",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2023-2024",
            "news_body": "Audited Financial Results and recommendation of final dividend for financial year 2023-2024",
            "news_id": "e1c31dae-aa36-4775-b186-0d10f0732cec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03d7bde5-dd2f-4817-b0d3-0dfaba3f9971.pdf",
            "news_date": "2024-05-10 16:16:26",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings call conducted on February 9, 2024",
            "news_id": "ab7e1537-7524-4d5d-99de-bbd7770d1d6a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a981ee48-44b2-49e6-baa2-ae0dc1fce75a.pdf",
            "news_date": "2024-02-13 15:30:16",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed the link of the audio recording of the Earnings call for the quarter and nine months ended December 31, 2023, conducted on February 9, 2024",
            "news_id": "dd29a3b3-6578-4982-a2f8-de804f75a630",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfddf7a1-a807-485e-ae9e-24a3042f7304.pdf",
            "news_date": "2024-02-09 19:41:26",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the Financial results of the Company for the quarter and nine months ended December 31, 2023",
            "news_id": "dbee088b-0a08-4635-bd67-4a24c6ced1eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c455ef46-db4e-4c0b-abf0-17e68b98e248.pdf",
            "news_date": "2024-02-08 17:25:49",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Unaudited Financial Results of the Company for the Quarter and Nine months ended December 31, 2023",
            "news_id": "e8ab7415-f80c-486b-8787-94dd6f95ce99",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bd66873-ef16-4c80-922f-b05f765cb1b6.pdf",
            "news_date": "2024-02-08 17:00:29",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed the link of the audio recording of the Earnings call for the quarter and half year ended September 30, 2023, conducted on November 7, 2023",
            "news_id": "6d9cd86d-5c63-4c5c-81f6-d05bdbbc2978",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=debd4512-19e3-4a71-86d6-2c9effdff6f1.pdf",
            "news_date": "2023-11-07 19:24:40",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors/Analysts Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 2023",
            "news_id": "09fc3a2e-3aad-4c1a-8605-80796a256b3e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ffa302c-2f95-4161-9be6-4b1063ce654b.pdf",
            "news_date": "2023-11-07 14:45:38",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "unaudited financial results of the Company for the quarter and half year ended September 30, 2023",
            "news_id": "da3832b0-19c4-4e53-9e52-fa5c20aabccd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0f87d26-d695-4da6-afc8-76b5834bb5cc.pdf",
            "news_date": "2023-11-07 14:38:43",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed the link of the audio recording of the Earnings call for the quarter ended June 30, 2023, conducted on August 3, 2023",
            "news_id": "c37204d0-fd24-45bf-93d1-37dd8fec917c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e8ef183-cd81-48a6-949b-a2230765202b.pdf",
            "news_date": "2023-08-03 20:38:03",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors/Analysts Presentation on the Financial Results of the Company for the quarter ended June 30, 2023",
            "news_id": "c3b70ecf-66a3-4870-b979-d9eb256bfe6a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c0927e7-fe04-4698-b924-a9b5e40dfc07.pdf",
            "news_date": "2023-08-03 15:19:16",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Quarter Ended June 30, 2023",
            "news_body": "Unaudited Financial results for quarter ended June 30, 2023",
            "news_id": "97e94603-5a56-46ec-ab37-0bb5dd9c6f6d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b21927a-5efd-437b-a0ea-7c5dce49ca39.pdf",
            "news_date": "2023-08-03 15:02:46",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For Quarter Ended June 30, 2023",
            "news_body": "Unaudited Financial results for quarter ended June 30, 2023",
            "news_id": "0816291b-276b-490f-a6e8-e06c9465f6ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=569f5609-d954-4b5c-9184-60344581b881.pdf",
            "news_date": "2023-08-03 14:57:44",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the link of the audio recording of the Earnings call for the quarter and year ended March 31, 2023, conducted on May 11, 2023",
            "news_id": "ebc90607-4c99-412e-8f63-368532dd0594",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12495cb0-647c-4c62-90ae-960eef52e2c4.pdf",
            "news_date": "2023-05-11 21:40:09",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors/Analysts Presentation on the Financial Results of the Company for the quarter and year ended March 31, 2023.",
            "news_id": "9365321d-f142-4443-a128-8a7e25e9379a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9f43e98-0724-45a5-8ba2-279fc94f2b33.pdf",
            "news_date": "2023-05-11 15:01:58",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 11, 2023 - Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2022-2023",
            "news_body": "Outcome of Board Meeting held on May 11, 2023 - Audited Financial Results and recommendation of Final Dividend for financial year 2022-2023",
            "news_id": "fe5dcfa6-50b7-4995-b7cb-a485c7a99a24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7448bafa-dc52-4e23-81ce-ba2d5901e1c2.pdf",
            "news_date": "2023-05-11 14:08:20",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On May 11, 2023 - Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2022-2023",
            "news_body": "Outcome of Board Meeting held on May 11, 2023 - Audited Financial Results and recommendation of Final Dividend for financial year 2022-2023",
            "news_id": "737a31cb-f31d-430d-844b-acdd684c6bd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfaa9cd3-8fba-4e73-8157-8c49910d960e.pdf",
            "news_date": "2023-05-11 14:02:18",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings call conducted on February 14, 2023",
            "news_id": "011a26b1-7403-4a0e-94f1-5e4475da5166",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48b60f33-48f3-4e3f-8dec-df3c1c7b1fc7.pdf",
            "news_date": "2023-02-17 14:23:07",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of The Earnings Call Conducted On February 14, 2023",
            "news_body": "Audio Recording of the earnings call conducted on February 14, 2023",
            "news_id": "1868ad10-7f81-4338-90a1-1b4ac0bc761b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ffd4c24e-6c9c-4b73-b4ff-e878dcd6aab6.pdf",
            "news_date": "2023-02-14 21:09:30",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022, Along With The Press Release And Investor Presentation.",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended December 31, 2022, Along With The Press Release And Investor Presentation.<BR>",
            "news_id": "fe509c82-6ac4-4329-925d-4bae89ccfec5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10d0de47-36d5-49cf-9d9f-9cd4398fa56e.pdf",
            "news_date": "2023-02-13 17:54:43",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings call conducted on November 10, 2022",
            "news_id": "8b012163-956c-44a3-8935-29daf2df9208",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efa2ad6f-15ab-4dc1-93db-71f5cc7dfd9e.pdf",
            "news_date": "2022-11-16 14:50:59",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For H1 FY23",
            "news_body": "Disclosure of Related Party Transactions for H1 FY23",
            "news_id": "c7227398-137f-4e99-b660-6f2e5eaa399a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0a7221e-2242-4598-8f50-973d12b64cd8.pdf",
            "news_date": "2022-11-14 12:36:17",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of The Earnings Call Conducted On November 10, 2022",
            "news_body": "Audio Recording of the earnings call conducted on November 10, 2022",
            "news_id": "4f812073-e102-43b1-9e95-bc18b53cbf42",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f138273e-8183-4ae9-835e-04d5b3534df4.pdf",
            "news_date": "2022-11-11 07:50:24",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Quarter And Half Year Ended September 30, 2022, Along With The Press Release And Investor Presentation.",
            "news_body": "Unaudited Financial Results for the quarter and half year quarter and half year ended September 30, 2022, Along With The Press Release And Investor Presentation.",
            "news_id": "03c867d3-5a22-4f2d-93ff-a123ce0c142e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83500419-c089-4f74-9511-c990c229c164.pdf",
            "news_date": "2022-11-10 18:17:16",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year, Along With The Press Release And Investor Presentation.",
            "news_body": "Unaudited Financial Results for the quarter and half year, Along With The Press Release And Investor Presentation.",
            "news_id": "8e247374-9514-41e6-aa21-782b8d21ab4b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcd36f7e-781f-4afa-a640-b0e8622a0b37.pdf",
            "news_date": "2022-11-10 18:15:07",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "Unaudited Financial Results For The quarter and half year ended September 30, 2022",
            "news_id": "a350256f-bcdf-4136-9722-bb275de6b4c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96527fb5-8a4a-4430-82e5-8191b02240c4.pdf",
            "news_date": "2022-11-10 13:51:55",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "8ec0c41e-7b51-484c-8385-d805a815df63",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e3cfb3d-b2ca-4a7e-883a-b9a1edbea761.pdf",
            "news_date": "2022-08-08 11:19:51",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recordings Of The Earnings Call Conducted On August 3, 2022",
            "news_body": "Audio Recordings Of The Earnings Call Conducted On August 3, 2022",
            "news_id": "d3379e7d-fa52-43a1-8d84-653c976f8e2d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20981d34-959a-4cbb-b380-3c9f496b4689.pdf",
            "news_date": "2022-08-03 19:32:49",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2022, Along With The Press Release And Investor Presentation.",
            "news_body": "Unaudited Financial Results For The Quarter Ended June 30, 2022, along with the Press Release and Investor Presentation.",
            "news_id": "b1cc3f49-9996-4d83-9db1-43e31011e475",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a65e776-4c5d-4fbd-b687-1a88dac42f23.pdf",
            "news_date": "2022-08-03 13:45:44",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure On Related Party Transactions For The Half Year Ended March 31, 2022 In Pdf Format.",
            "news_body": "We refer to our submission of Related Party Transactions pursuant to Regulation 23(9) of SEBI Listing Regulations, 2015 through XBRL on May 20, 2022. Further, please find enclosed herewith the disclosure on Related Party Transactions for the half year ended March 31, 2022 in pdf format.",
            "news_id": "4973388e-398d-4619-bede-6faa371c2c85",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58596d56-f08c-4436-bf49-f2374ace3be9.pdf",
            "news_date": "2022-06-01 16:13:39",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation to our intimation dated May 5, 2022, we would like to inform you that the audio recording and the transcript (attached) of the Earnings Call on Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2022, held on May 10, 2022, have been uploaded on the website of the Company on May 10, 2022 and May 13, 2022 respectively. Please find below the weblinks to access the same:Web link to access audio recording is as under:https://www.neulandlabs.com/investors/investor-updates/investors-call-recordings/Web link to access above transcript is as under:https://www.neulandlabs.com/investors/investor-updates/announcements/This is for your information and records.",
            "news_id": "771b67cb-660e-4ff1-a845-d93ac20a5fd0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee9433b0-eeee-40ec-b3a3-1474ab4c7287.pdf",
            "news_date": "2022-05-31 15:28:24",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting, Audited Results And Recommendation Of Final Dividend, For The Year Ended March 31, 2022",
            "news_body": "Outcome of Board Meeting, Audited results and recommendation of final dividend, for the year ended March 31, 2022",
            "news_id": "67a0211a-862b-4e4f-bdb9-fec7160eee0a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab44d6be-d036-4101-9f5a-6dbd404b9ada.pdf",
            "news_date": "2022-05-10 16:52:20",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For The Year Ended March 31, 2022",
            "news_body": "Results-Financial Results for the year ended March 31, 2022",
            "news_id": "af00872e-56bc-49e3-81b4-f0fded0764b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86c66152-b01d-433d-9d41-d4801779e422.pdf",
            "news_date": "2022-05-10 16:48:28",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2021 Along With Press Release And Investor Presentation",
            "news_body": "Unaudited Financial Results for the Quarter and nine months ended December 31, 2021 along with Press Release and Investor Presentation",
            "news_id": "66c191a5-7aa2-4481-b6ce-accc50686ae4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b231c61-44f7-4243-bd80-219ef4728624.pdf",
            "news_date": "2022-02-01 14:35:33",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2021 Along With Press Release And Investor Presentation",
            "news_body": "Unaudited Financial Results for the quarter and half year ended September 30, 2021 along with Press Release and Investor Presentation",
            "news_id": "7a247822-3965-4493-8c27-5d01388adae3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fda76e1-135d-46eb-a16b-1b7f86c1d40f.pdf",
            "news_date": "2021-10-29 14:37:41",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For June 30, 2021 Along With Press Release And Investor Presentation",
            "news_body": "Unaudited Financial Results For June 30, 2021 along with Press Release and Investor Presentation",
            "news_id": "79f9b865-5882-4f07-a5ef-8edfa40e0ada",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f5bccf2-21fa-4b2c-a2f7-5eaace930fc5.pdf",
            "news_date": "2021-08-03 14:31:01",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure On Related Party Transactions For Half Year Ended March 31, 2021",
            "news_body": "Disclosure on Related Party Transactions for half year ended March 31, 2021",
            "news_id": "ea55244a-9367-4e34-bcb0-d723a32c4363",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec3846a4-85c8-467f-b2cf-e1a16e7abc04.pdf",
            "news_date": "2021-06-01 17:46:02",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NEULANDLAB",
            "disp": "Neuland Laboratories",
            "bse_code": 524558,
            "isin": "INE794A01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For March 31, 2021",
            "news_body": "Results-Financial Results for March 31, 2021",
            "news_id": "09ede59a-66f6-4509-b7bd-36e261afddc6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96c02733-1c97-4eb0-b4f1-50c05f396ba5.pdf",
            "news_date": "2021-05-11 15:04:19",
            "seo": "neuland-laboratories-ltd",
            "ltp": 13190,
            "ch": -312,
            "pch": -2.310768774996297,
            "inst": "EQUITY",
            "ts": 1,
            "ls": 1,
            "mtp": 1,
            "sid": 2406,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}